218
Participants
Start Date
May 31, 2008
Primary Completion Date
November 30, 2011
Study Completion Date
November 30, 2011
Obatoclax
IV Infusions for 3 consecutive days of either 3-hours, 2 hours duration
Carboplatin/etoposide
Carboplatin/etoposide combination
University of Pennsylvania Abramson Cancer Center, Philadelphia
Greater Philadelphia Cancer and Hematology Specialists, Philadelphia
Georgetown University Hospital-Lombardi Comprehensive Cancer Center, Washington D.C.
Center for Cancer and Blood Disorders, Bethesda
Virginia Oncology Associates, Norfolk
Peninsula Cancer Institute, Newport News
Wheeling Hospital, Wheeling
Cancer Centers of the Carolinas, Greenville
Northwest Georgia Oncology Centers, Marietta
Integrated Community Oncology Network, Jacksonville
University of Miami-Sylvester Cancer Center, Miami
H. Lee Moffitt Cancer Center, Tampa
Northwest Alabama Cancer Center, Muscle Shoals
Clearview Cancer Institute, Huntsville
McLeod Cancer & Blood Center, Johnson City
The West Clinic, Memphis
James Brown Cancer Center, Louisville
Mid Ohio Oncology/Hematology, Inc., Columbus
Kalamazoo Hematology and Oncology, Kalamazoo
Iowa Blood and Cancer Center, PLC, Cedar Rapids
University of Chicago, Chicago
Cancer Center of Kansas, Wichita
Cancer Care Associates-Oklahoma City, Oklahoma City
Cancer Care Associates-Tulsa, Tulsa
Baylor, Dallas
Tyler Cancer Center, Tyler
Mayo Clinic-Arizona, Scottsdale
Arizona Clinical Research Center, Tucson
City of Hope and Beckman Research Institute, Duarte
University of California-San Diego Moores Cancer Center, La Jolla
Florida Cancer Institute, New Port Richey
UT Southwestern Medical Center at Dallas, Dallas
"MHAT Dr. Tota Venkova", Gabrovo
District Dispensary for Cancer Diseases, Plovdiv, Plovdiv
District Dispensary for Oncology Diseases, Sofia City, Sofia
Specialized Hospital for Active Treatment in Oncology, Sofia
Regional Hospital Kladno, Kladno
Hospital Kutna Hora, Kutná Hora
University Hospital Olomouc, Olomouc
Faculty Hospital Ostrava, Ostrava-Poruba
University Hospital Na Bulovce, Prague
National Institute of Tuberculosis & Pulmonology, Budapest
Semmelweis University Medical School, Budapest, Budapest
University Of Debrecen Medical and Health Science Centre, Debrecen
Csongrad County Council's Hospital for Chest Diseases, Deszk
Bacs-Kiskun County Hospital, Kecskemét
State Hospital Matrahaza, Mátraháza
Clinfan Ltd. SMO Tolna County Hospital, Szekszárd
Pest County Hospital, Törökbálint
Vedanta Institute of Medical Sciences, Ahmedabad
Kailash Cancer Hospital and Research Centre, Goraj
Jawaharlal Nehru Cancer Hospital and Research Centre, Bhopal
Curie Manavata Cancer Centre, Nashik
Noble Hospital, Pune
Dr. Kamakshi Memorial Hospital, Chennai
Galaxy Cancer Institute, Pushpanjali Crosslay Hospital, Ghaziabad
Orchid Nursing Home, Kolkata
Wojewodzki Szpital Specjalistyczny im. K. Dluskiego, Bialystok
SPZ Gruzlicy i Chorob Pluc, Olsztyn
Mazowieckie Centrum Leczenia Chorob Pluc i Gruzlicy, Otwock
Specjalistyczny Szpital im Prof Alfreda Sokolowskiego, Szczecin-Zdunowo
Wojewodzki Szpital Chorob Pluc, Wodzisław Śląski
Prof. Dr. Ion Chiricuta Oncology Institute Cluj Napoca, Cluj-Napoca
Oncology Medical Centre SCM, Iași
Emergency Clinical County Hospital Oradea, Oradea
Institute for Pulmonary Diseases of Vojvodina, Kamenitz
Center for Pulmonary Diseases, Clinic for Internal Medicine, Kragujevac
Northern Ireland Cancer Centre Queens University Belfast, Belfast
Royal Bournemouth Hospital, Dorset
Nottingham University Hospital, Nottingham
Weston Park Hospital, Sheffield
Royal Surrey County Hospital, Surrey
Tom Baker Cancer Centre, Calgary
Cross Cancer Institute, Edmonton
McGill University, Montreal